Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 170

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 170
---
 2025 Warrants, provided however that those purchasers who do not enter into the Purchase Agreement and do not provide us with information required for registration of the shares of Common Stock to be issued upon an Anti-Dilution Adjustment shall not be able to effect a cashless exercise with respect to Warrant Shares issuable upon the triggering of the Anti-Dilution Adjustment.

| 82 |

Fractional Shares

No fractional shares of Common Stock will be issued upon the exercise of the May 2025 Warrants. Rather, the number of shares of Common Stock to be issued will be rounded up to the next whole share or we will pay a cash adjustment equal to such fraction multiplied by the exercise price to the holder.

Transferability

Subject to applicable laws, a warrant may be transferred at the option of the holder upon surrender of the warrant to us together with the appropriate instruments of transfer.

Trading Market

There is no trading market available for the May 2025 Warrants on any securities exchange or nationally recognized trading system, and we do not expect a trading market to develop. We do not intend to list the May 2025 Warrants on any securities exchange or other trading market. Without a trading market, the liquidity of the May 2025 Warrants will be extremely limited. The Common Stock issuable upon exercise of the May 2025 Warrants is currently listed on the Nasdaq Capital Market.

Rights as a Stockholder

Except as otherwise provided in the May 2025 Warrants or by virtue of such holder’s ownership of shares of our Common Stock, the holders of the May 2025 Warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they exercise their May 2025 Warrants.

Warrant Agent; Global Certificates.

The May 2025 Warrants
will be issued in registered form under a Warrant Agent Agreement between the Warrant Agent and us. The May 2025 Warrants will
be unregistered securities and will be evidenced by a global certificate, which shall be deposited on behalf of the Company with the
Warrant Agent. Our transfer agent, VStock Transfer, LLC, will serve as the Warrant Agent.

Fundamental Transaction

In the event of a fundamental transaction, as described in the May 2025 Warrants and generally including any reorganization, recapitalization or reclassification of our Common Stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or